.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Boehringer Ingelheim
Accenture
UBS
Queensland Health
McKinsey
Citi
Cantor Fitzgerald
Merck

Generated: November 18, 2017

DrugPatentWatch Database Preview

ERTACZO Drug Profile

« Back to Dashboard

What is the patent landscape for Ertaczo, and when can generic versions of Ertaczo launch?

Ertaczo is a drug marketed by Valeant Luxembourg and is included in one NDA.

The generic ingredient in ERTACZO is sertaconazole nitrate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the sertaconazole nitrate profile page.

Summary for ERTACZO

Pharmacology for ERTACZO

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Luxembourg
ERTACZO
sertaconazole nitrate
CREAM;TOPICAL021385-001Dec 10, 2003RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ERTACZO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg
ERTACZO
sertaconazole nitrate
CREAM;TOPICAL021385-001Dec 10, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Argus Health
Medtronic
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
McKesson
Merck
Baxter
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot